Molecular Pharmaceutics and Drug Delivery

Molecular Pharmaceutics and Drug Delivery is comprised of those disciplines that are involved with dosage forms in pharmaceutical practice. Sub-disciplines within the division include: 1) Formulation Science in which physics and chemistry are used to prepare effective dosage forms, 2) Biopharmaceutics in which the interactions between the dosage form, itself, and various biological factors in the persons taking the dosage form are studied, and 3) Pharmacokinetics in which the time course of drugs in the body and the factors influencing the time course are studied analytically and mathematically.

Pharmaceutics Students 2016


Division Research

Feng Zhang videoWhile students choose one particular area of pharmaceutical research, they will be exposed to many other aspects of the pharmaceutical sciences in order to round out their educational experience. Distinguished faculty in the division supervise their program of study and their research experiences.  Learn more about Dr. Feng Zhang’s research.

 

 


Ph.D. Graduate Program

Pharmaceutics Graduate StudentGraduate degrees are awarded for the student’s demonstration of mastery of a selected field and independent scholarship therein. The program of study is tailored to best suit each student’s interests and professional goals while maintaining the standards established by the student’s supervisory committee and the division. Each student is required to select at least 18 hours from a list of “core” courses in pharmaceutics, physical chemistry, general chemistry, mathematics and statistics. Additional coursework is encouraged.

Following completion of the core course requirements, the student takes a written candidacy examination authored by all members of the student’s examining committee. Typically, the examining committee consists of the same members as the supervisory com mittee. The student also submits to his supervisory committee a written proposal describing the proposed dissertation/thesis research and then presents the proposal in an oral proposal defense.

The core course requirements, the written candidacy examination, the written research proposal, and the oral proposal defense constitute the Ph.D. candidacy requirements within the Molecular Pharmaceutics and Drug Delivery Division. The Master’s candidacy requirements are the same except that no written candidacy examination is required. The degree requirements include the candidacy requirements plus preparation and oral defense of a dissertation (Ph.D.) or thesis (Master’s) based upon original research. Successful completion of the Ph.D. candidacy requirements must be accomplished at least one year prior to the date of the dissertation defense. Visit the degree requirements page for details about the curriculum and  division-specific requirements.

Eligibility & Admissions

Applicants should have a baccalaureate degree in a discipline such as pharmacy, chemistry, biochemistry or a biological science. This training should include coursework in each of the following: one year each of physical chemistry, organic chemistry, a biological or pharmaceutical science and calculus.

Additional details about eligibility and admissions can be found on the Research & Graduate Studies site.


Spotlight on Success

moralesThe Division of Molecular Pharmaceutics and Drug Delivery is proud to recognize the accomplishments of one of our recent graduates, Javier O. Morales, Ph.D. (2012; McConville/Williams). Dr. Morales recently hosted two graduate student workshops at the University of Chile titled “Formulating Poorly Water Soluble Drugs” and “Publishing Strategies for Pharmaceutical Scientists.” He is an Assistant Professor in the Department of Pharmaceutical Science and Technology at the School of Chemical and Pharmaceutical Sciences of the University of Chile and an Associate Researcher in the Advanced Center for Chronic Diseases (ACCDiS). Dr. Morales received his Bachelor of Science in Pharmacy (2006) and a Professional Degree in Pharmacy (2007) at the University of Chile; and his Ph.D. from The University of Texas at Austin (2012), after which he joined the faculty at the University of Chile (2013).


AAPS 2016 Poster Presentations

MONDAY, NOV 14

Controlled Synthesis of Bisphosphonate-Calcim Composites and Their Potential for Reducing Immunosuppressive Macrophages in Tumor Micoenvironment
Li, Xu (Post Doc)
10 a.m., Terminal 31

Acid-Sensitive Sheddable PEGylated Nanoparticles for Targeted Delivery to Chronic Inflammation Sites
O’Mary, Hannah
10 a.m., Terminal 26

A Novel Acid-Sensitive TNF-α siRNA Nano-formulation for Potential Treatment of Chronic Inflammation Treatment of Chronic Inflammation
Abdulaziz, Aldayel (Dayel)
11 a.m., Terminal 15

Solvent-Assist Hot-Melt Extrusion Technique Minimizes Thermal-Labile Drug Degradation
Huang, Siyuan
12:30 p.m., Terminal 19

Interpolymer Complexation between Copovidone and Carbopool and its Effect on Drug Release from Matrix Tablets
Zhang, Feng/Na, W.
1 p.m., Terminal 26

The Preclinical Evaluation of Toxicity of 4-(N)-Docosahexaenoyl 2′,2′ – Difluorodeoxycitidine, a Compound with Potent Antitumor Activity
Valdes, Solange
3 p.m., Terminal 35

Improving the Stability of Aluminum Salt-Adjuvanted Vaccine to Freezing and Heat by Thin-Film Freeze-Drying
Thakkar, Sachin
4 p.m., Terminal 15

TUESDAY, NOV 15

Evaluation of Ciprofloxacin-Copper Complex to Treat Pulmonary Pseudomonas aeruginosa Biofilms
Bahamondez, Tania
10 a.m., Terminal 5

Chitosan-Derived Nanoparticle as a Carrier for Non-Viral CRISPR/Cas9 System Delivery
Zhang, Hairui
10:30 p.m., Terminal 20

Effect of Integrin Receptors on Nuclear Receptors Regulatating CYP3A under Infectious and Non-Infectious Conditions
Jonsson-Schmunk, Kristina
11:30 p.m., Terminal 20

AFFINISOL™ HPMC Melt-Extruded Matrix Tablet for Controlled Release of Soluble Drugs
Maincent, Julien
12:30 p.m., Terminal 27

Macrorheology Characterization of a Cystic Fibrosis Mucus Model
Leal, Jasmim
1 p.m., Terminal 13

Understanding Extrusion Processing Conditions to Improve Chemical Stability of a Meloxicam-Copovidone Amorphous Solid Dispersion
Haser, Abbe
3 p.m., Terminal 27

Processing of Thermally Labile Active Ingredient by Hot-melt Extrusion
Huang, Siyuan
3 p.m., Terminal 28

Preparation and Characterization of Spray-Dried Powders of Voriconazole and Calcium Phosphate Nanoparticles for Pulmonary Administration
Tarbox, Tamara
3:30 p.m., Terminal 2

Shadow Motion Analysis: Analyzing In Vivo Relevant Foam Stability by Image Analysis
Warnken, Zachary
3:30 p.m., Terminal 12

In-Situ Salt Formation during Reactive Melt Extrusion Improve the Dissolution Rate and Physical Stability of Naproxen Amorphous Solid Dispersions
Liu, Xu
3:30 p.m., Terminal 25

WEDNESDAY, NOV 16

Mucoadhesive Amorphous Solid Dispersions
Ellenberger, Daniel
8:30 a.m., Terminal 2

Development of Aerosolized Voriconazole Formulations for Dry Powder Inhalation
Moon, Chaeho
8:30 a.m., Terminal 24

Modified Microtiter Plate Method for Biofilm Susceptibility Testing
Bahamondez, Tania
9:30 a.m., Terminal 13

Delivery of Membrane Protein Connexin to Mestatic Cancer Cells Using Cell-derived Vesicles
Ferrati, Silvia (Post doc)
10:30 a.m., Terminal 16

Investigating the effect of Polymer-Polymer Interaction at Molecular Level on the Properties of Ternary Amorphous Solid Dispersion
Meng, Fan
1:30 p.m., Terminal 20

Incorporation of Copovidone to Improve the Properties of Poly(Vinyl Alcohol)-Based Itraconazole Amorphous Solid Dispersions
Zhang, Feng/Wlodarski, K.
3:30 p.m., Terminal 28

THURSDAY, NOV 17

Effect of Formulation, Device and Ambient Temperature on Plume Structure of Solution pMDIs
Moraga-Espinoza, Daniel
8 a.m., Terminal 23

Functionally Engineered and Optimized Iron Oxide Nanoparticles for Treating Biofilms
Heersema, Lara
8:30 a.m., Terminal 29

Reverse engineering a Monodose Dry Powder Inhlaer by Laser Diffraction and RODOS Disperser
Moraga-Espinoza, Daniel
8:30 a.m., Terminal 35

Spray Coating Optimization of Hygroscopic Substrates for Controlled Release
Ferrati, Silvia (Post Doc)
9 a.m., Terminal 18

Phage Display Technology to Identify Blood-Brain Barrier Penetrating Peptides
Peng, Xiujuan (Sophie)
9 a.m., Terminal 15

Development and Validation of HPLC Assay Method for Stability Testing of a High-Potency Diclofenac Sodium Gel
Tarbox, Tamara
9:30 a.m., Terminal 12

Optimization of Novel Active Dry Powder Inhaler
Brunaugh, Ashlee
9:30 a.m., Terminal 26


HELPFUL LINKS FOR APPLICANTS

Pharmaceutical Sciences Graduate Program
Pharmaceutics Faculty
Eligibility and Evaluation of Applicants
Application Procedures

HELPFUL LINKS FOR CURRENT STUDENTS

Research & Graduate Studies
Graduate Student Resources
Poster Design and Printing Services
Research Day
PGSA


Facebook link iconMake a Gift
Texas Pharmacy: The University of Texas at Austin College of Pharmacy